Drugs agency reminds companies of duty to report side effects
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7343.938/b (Published 20 April 2002) Cite this as: BMJ 2002;324:938- Rory Watson
- Brussels
The London based European Agency for the Evaluation of Medicinal Products is reminding pharmaceutical companies of their responsibility to report any previously unknown side effects that might emerge when new drugs are put on the market.
The initiative reflects the agency's determination since the start of the year to emphasise its establishment of a strong pharmaceutical vigilance system to ensure the safety of drugs, in addition to its role of granting licences for new products.
Under existing rules companies have to report any adverse effects …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.